Transobturator mid-urethral sling in females with stress urinary incontinence and detrusor underactivity: effect on voiding phase.
Adult
Aged
Diagnostic Techniques, Urological
/ statistics & numerical data
Female
Humans
Middle Aged
Postoperative Complications
/ diagnosis
Prospective Studies
Risk Factors
Sensitivity and Specificity
Suburethral Slings
/ adverse effects
Surveys and Questionnaires
Urinary Bladder, Underactive
/ complications
Urinary Incontinence, Stress
/ complications
Urinary Retention
/ diagnosis
Urination
Urodynamics
Detrusor underactivity
Long-term follow-up
Projected isovolumetric pressure
Quality of life
SUI surgery
Trans-obturator mid-urethral sling
Uncomplicated SUI patients
Urodynamics
Voiding dysfunction
Journal
International urogynecology journal
ISSN: 1433-3023
Titre abrégé: Int Urogynecol J
Pays: England
ID NLM: 101567041
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
received:
11
10
2018
accepted:
03
01
2019
pubmed:
5
2
2019
medline:
9
4
2020
entrez:
5
2
2019
Statut:
ppublish
Résumé
To assess whether detrusor underactivity (DU) is a risk factor for voiding dysfunction (VD) after transobturator tape (TOT) and if a detrusor pressure at maximum flow (PdetQmax) value predicts postoperative VD in DU patients. Also, we examined uncomplicated patients for postoperative VD. This is a prospective long-term study on SUI patients who underwent TOT. Exclusion criteria were preoperative POP stage ≥ 2, previous anti-incontinence surgery and comorbidities. Patients were grouped by detrusor contractility using the projected isovolumetric pressure (PIP) index (PdetQmax + maximum flow rate) with values of 30-75 cmH In 2007-2013, 118 patients underwent TOT. We included 50 in the undercontractility group (G1) and 50 in the normocontractility group (G2). Continence rates were 82% in G1 and 84% in G2 (mean follow-up 76 months). VD increased from 18 to 36% (p < 0.05) in G1 and from 14 to 16% (p = 0.198) in G2. De novo VD was 28% in G1 and 2% in G2. In the G1 group PdetQmax ≤ 12 cmH DU adversely affects the voiding phase of micturition after TOT. In DU patients, PdetQmax ≤ 12 cmH
Identifiants
pubmed: 30715577
doi: 10.1007/s00192-019-03871-7
pii: 10.1007/s00192-019-03871-7
doi:
Types de publication
Evaluation Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1519-1525Références
Scand J Urol Nephrol Suppl. 2004;(215):93-100
pubmed: 15545203
BJU Int. 2006 Sep;98 Suppl 1:32-40; discussion 41-2
pubmed: 16911600
Am J Obstet Gynecol. 2002 Jul;187(1):49-52
pubmed: 12114887
Am J Obstet Gynecol. 2002 Jul;187(1):116-26
pubmed: 12114899
J Urol. 2003 Mar;169(3):1011-2
pubmed: 12576833
Br J Obstet Gynaecol. 1997 Dec;104(12):1374-9
pubmed: 9422015
Eur Urol. 2007 Mar;51(3):782-7; discussion 787
pubmed: 17098355
World J Urol. 1995;13(1):47-58
pubmed: 7773317
Prog Urol. 2001 Dec;11(6):1306-13
pubmed: 11859672
Am J Obstet Gynecol. 1996 Jul;175(1):10-7
pubmed: 8694033
Curr Urol Rep. 2005 Sep;6(5):356-9
pubmed: 16120236
Int Neurourol J. 2017 Dec;21(4):282-288
pubmed: 29298467
Eur Urol. 2014 Feb;65(2):389-98
pubmed: 24184024
BJU Int. 1999 Jul;84(1):14-5
pubmed: 10444116
Neurourol Urodyn. 1996;15(6):599-613; discussion 613-8
pubmed: 8916113
Obstet Gynecol. 1999 Jul;94(1):99-102
pubmed: 10389726
Am J Obstet Gynecol. 2014 Jul;211(1):71.e1-71.e27
pubmed: 24487005
Br J Urol. 1973 Oct;45(5):497-507
pubmed: 4270633
Urology. 1999 Aug;54(2):268-72
pubmed: 10443723
Korean J Urol. 2015 Dec;56(12):823-30
pubmed: 26682023
Contrib Gynecol Obstet. 1983;10:51-69
pubmed: 6685605
Eur Urol. 2006 Dec;50(6):1323-9
pubmed: 16713067
Obstet Gynecol. 2003 May;101(5 Pt 1):929-32
pubmed: 12738152
Int Urogynecol J. 2010 Jan;21(1):5-26
pubmed: 19937315
Int Braz J Urol. 2011 Jan-Feb;37(1):100-7
pubmed: 21385486
Neurourol Urodyn. 2017 Feb;36(2):518-528
pubmed: 26950893
J Urol. 2003 Jun;169(6):2234-7
pubmed: 12771757
J Urol. 2002 May;167(5):2093-7
pubmed: 11956447
J Urol. 2003 Sep;170(3):852-6
pubmed: 12913715
Female Pelvic Med Reconstr Surg. 2019 Jan/Feb;25(1):63-66
pubmed: 29135810